Veterinary scientist, Dr Alex German and veterinary nurse, Shelley Holden are joining presenter and vet, Mark Evans in a new Channel Four series exploring the secret life of dogs, the first of which airs tonight at 8:00pm.

The three-part series looks at how people's lives and those of their dogs have radically changed in the last 50 years.

Using hidden cameras, episode one investigates how dogs gain weight when their owners are not present or out at work, as well as what research is being done to understand the UK's obesity epidemic in dogs and cats.

Alex, who is head of the University's Weight Management Clinic, said: "Obesity is common in dogs and can lead to a range of illnesses and diseases.

"Although treatment for weight loss has been in existence for some time it has not been without its problems, and owners, with busy lives, can find it difficult to even understand how their dog has gained weight in the first place.

"By showing what dogs get up to out of their owner's sight, this programme explores how understanding our animals' behaviour and habits can help in producing a healthy diet and exercise regime."

Dr German has also contributed to the Channel Four website, which provides information for owners and access to case studies: http://dogs.channel4.com/fat-dogs/

Lumbry Park Veterinary Specialists, a small animal referral hospital in Alton, Hampshire and part of the CVS Group, has announced a partnership with the Evelina London Children’s Hospital to promote the concept of ‘One Health’. 

The partnership happened after Lumbry Park’s Clinical Director, veterinary cardiologist, Dr Luca Ferasin and his wife Heidi had a son, Mattia, with multiple and life-threatening congenital heart defects. During their son's subsequent treatment, which involved seven hours of successful open heart surgery, Dr Ferasin and his wife got to know Dr Caner Salih, a consultant paediatric cardiac surgeon and member of the team caring for Mattia. So when Dr Salih acquired French Bulldog puppy called Büdu a few weeks later, and a heart murmur was detected during his first visit to the vet, he turned to Dr Ferasin for advice.

Dr Ferasin diagnosed Büdu with the congenital heart condition Perimembranous Ventricular Septal Defect (VSD). A VSD is characterised by a hole between the left and right ventricles of the heart which causes an abnormal blood flow between the two chambers. Ironically, a large VSD was one of the multiple heart defects successfully corrected during Mattia’s life-saving cardiac surgery.  

Dr Salih said: "I first met Dr Ferasin and Heidi under one of the most stressful circumstances a parent can experience, that of waiting for a child to undergo life-saving cardiac surgery. Sometime later I had first-hand experience of something not comparable but nonetheless very stressful of having to wait for the results of a diagnostic test which Dr Ferasin was able to provide for our newly acquired puppy. I appreciated more than ever the importance of knowing that our newest family member was in the most capable of hands."

Dr Ferasin said: "The related stories of Mattia and Büdu highlight the remarkable similarities between paediatric and small animal medicine, not only in terms of medical conditions, diagnostic techniques and therapeutic procedures, but also in terms of the psychological, emotional and social importance of the human-animal bond –  in both directions. After all, just like babies and young children, veterinary patients cannot communicate with us - while their ‘parents’ have the same need for reassurance that their beloved ‘baby’ will recover. 

"Our partnership with the Evelina London Children’s Hospital will celebrate these similarities and promote the concept of ‘One Health’ in a bid to advance both human and veterinary medicine. By working closely with the Evelina London, we aim to contribute positively to the development of novel techniques, research and therapies in both our children and in companion animals. We’re planning a range of initiatives, including fundraising and collaborations with the clinical staff at Lumbry Park and the Evelina London, in particular with those in the cardiology and cardiac surgery departments. We’re also planning social events, such as advanced pet-therapy sessions for children undergoing treatment at the Evelina and their families, including direct interaction with our veterinary patients with similar conditions."

He added: "Thanks to the dedicated team at the Evelina London Children’s Hospital, Mattia is thriving and is a happy, healthy and fun-loving little boy. He will continue to visit the hospital for reassessments as he grows.  Büdu visited us again at Lumbry Park during 2016 for a reassessment and an ultrasound of his heart showed the spontaneous closure of his VSD, resulting in the resolution of his condition. This is a rare but fantastic outcome which, to the best of our knowledge, has only been reported in a couple of canine cases in the veterinary literature. What better reason to cement the bond between human and veterinary medicine!"

Dr Salih added: "Many people do not appreciate the amount of shared learning that has, for decades, occurred between the study of animals and medicine. Many of the advances in areas of human healthcare we embrace today simply could not exist without this relationship – and open heart surgery is one. The Evelina is delighted to be collaborating with Lumbry Park on this exciting venture."

Grahame Gardner Ltd has announced the launch of a classically styled tunic, the M559, now stocked in bottle green for the first time.

The company says that although there have been numerous ladies tunics available in bottle green, this is the first time Grahame Gardner has stocked a male tunic in the characteristic veterinary colour.

The contemporary design of the M559 incorporates side fastening with the option of contrasting epaulettes, alongside practical pockets and side slits. According to the company, it's a tunic that looks great and performs exceptionally well in the veterinary practice. Stocked in sizes from 34" to 50" (chest), the M559 is one of several new styles introduced within Grahame Gardner's latest 124 page brochure.

To explore Grahame Gardner's collection please take a look at http://www.grahamegardner.co.uk/, or call 0116 255 6326 to order a copy of the new brochure.

The European Commission has agreed with the BSAVA and BVA that controls must be maintained to keep the UK free from the tapeworm Echinococcus multilocularis, and adopted a regulation that will permit pre-movement treatment for dogs travelling to listed Member States (i.e. the UK, Ireland, Finland and Malta).

In June Defra announced that the UK's derogation from European pet travel rules, which allows additional protection for the UK against rabies, ticks and tapeworms, would end on 31 December 2011. The movement rules on rabies and ticks will now be harmonised with the rest of Europe.

However, due to the significant public health risk posed by Echinococcus multilocularis, the BVA and BSAVA (working with Defra, the Federation of Veterinarians of Europe [FVE] and colleagues in Veterinary Ireland) continued to lobby the European Commission for controls on tapeworms to be maintained.

The regulation will ensure that a dog must be treated by a veterinary surgeon 24 to 120 hours (1-5 days) before entering one of the listed countries.

The BVA and BSAVA say they made a scientific case for a treatment window of 24-48 hours, but accept that the Commission had to find a compromise that would assist pet owners travelling during national holidays.

Harvey Locke, President of the BVA said: "This has been a long process but the BVA and BSAVA put forward the strong scientific case for the UK to maintain tapeworm controls and we are delighted that the European Commission has adopted this resolution.

"In our role as guardians of public health, vets were deeply concerned that the removal of tapeworm controls would see the introduction of EM to the UK and Ireland.

"Although relatively benign in dogs, the resulting disease in humans - alveolar echinococcosis - is an invasive, cancer-like cystic stage of the parasite, and is invariably fatal if not treated.

"The next stage of our lobbying will be to ensure that Member States and MEPs from across Europe support the UK's case for the additional controls."

Andrew Ash, President of BSAVA said: "Echinococcus multilocularis is a significant public health threat and we have worked hard to ensure the European Commission understands the potential impact of allowing this zoonotic disease to enter our country.

"The BVA and BSAVA will continue to promote the best possible health and welfare advice for pet owners taking their animals abroad. Our advice to owners is to speak to a vet as early as possible to make sure pets are protected from all diseases and parasites encountered abroad."

The BVA is calling on veterinary practices to embrace flexible working after stats from its Autumn 2021 Voice of the Profession survey showed that 44% of vets would like to work more flexibly.

With recruitment and retention issues in many sectors of the profession, the Association says flexible working might improve job satisfaction and therefore retention.

Other statistics from the survey showed that whilst levels of flexible working have risen from 44% in 2019 to 50% in 2021, 36% of those who already work flexibly 36% would like more flexibility.

The most common reasons vets gave for wanting to work more flexibly were: to allow more time for leisure activities (56%), lifestyle needs (50%), caregiving responsibilities (28%), health reasons (28%), for professional development (22%) and for voluntary work (16%). 

The type of flexibility vets were hoping to achieve also varied. Working part time was the most common type of flexible working sought (31%), followed by homeworking (16%), flexitime (13%) and compressed hours (5%).

As part of its campaign, the BVA has launched "Flexible working: Embracing flexibility in the veterinary profession", a booklet which includes facts, figures and case studies to help demonstrate how flexible working can benefit both employers and employees in a range of different veterinary teams.

The booklet also offers tips and advice on tackling some of the challenges that can arise when introducing increased flexibility into a clinical workplace.

BVA Junior Vice President Malcolm Morley said: “The statistics clearly show that there is a huge appetite for more flexibility in working hours, particularly in clinical practice, where employers have previously been quite hesitant to explore this option.

"We understand that there are potential challenges to allowing more flexibility but we’re hoping to demonstrate that these are not insurmountable.

“It’s vital that the profession recognises that inflexible working patterns contribute to poor retention—recognition is the first stage in finding a solution.

"Embracing developments in flexible working could increase job satisfaction for many team members and ultimately improve retention.”

Malcolm added: “The profession continues to face serious staffing shortages and we understand that the increased pressures on vet teams may make some employers anxious about introducing flexible working at a time when they are already struggling to cover shifts.

"However, the solution does not lie with vet teams working increasingly longer hours; a successful solution will need team members to be involved in supporting each other’s working patterns.

"Promoting a better balance between home and work could be key to supporting many staff who are currently unsure about remaining in the profession or returning to work."

www.bva.co.uk/flexible-working

Improve International has launched a new accredited General Practitioner Advanced Certificate (GPAdvCert) for veterinary professionals across Europe who want to advance their knowledge and practical skills in a particular field.

Modules for the first GPAdvCert – in Small Animal Orthopaedics – will begin in February 2018.  Improve says it's the first of many 'next steps' programmes which it plans to launch under this new postgraduate level qualification.  

The GPAdvCert in Small Animal Orthopaedics is aimed at veterinary surgeons who have completed their General Practitioner Certificate in Small Animal Surgery (GPCert SAS) or Postgraduate Certificate (PgC) in Small Animal Surgery.

Accredited by the European School of Veterinary Postgraduate Studies (ESVPS) and validated by Harper Adams University, the programme is delivered over 15 modules in three state-of-the-art European training centres - Sheffield, UK, Cremona, Italy and Madrid, Spain. Improve says delegates will learn from world-class clinicians and will be supervised in their practise of new surgical techniques and advanced procedures in a wet-lab environment.

David Babington MRCVS, Managing Director of Improve International (pictured right), said: "We felt there was a gap in the current structure for a postgraduate qualification which would allow students to advance their knowledge and practical skills in their chosen area and to add to their academic credentials. The General Practitioner Advanced Certificate is our solution."

Successful achievement of the GPAdvCert will enable delegates to progress from a Postgraduate Certificate in Small Animal Surgery (or equivalent) to the Postgraduate Diploma in Advanced Veterinary Practice Sciences in the UK, which is awarded by Harper Adams University. This can, in turn, be used towards the award of a Masters Degree (MSc) in Advanced Veterinary Practice Sciences.

David added: "Delegates for our first GPAdvCert in Orthopaedics for Small Animals will enhance their skills and confidence in dealing with more advanced orthopaedic procedures in-house and this will help them to reduce the number of patients which are referred, retaining a higher level of income for their practice. They will also develop skills which they can pass onto their team. We look forward to welcoming our first delegates next year."

Further details are available at: https://www.improveinternational.com/uk/course/general-practitioner-advanced-certificate-in-small-animal-orthopaedic-surgery/ 

HT Vista has had a paper published in Frontiers of Veterinary Science which it says validates the use of its thermal imaging and AI device for accurate screening of dermal and subcutaneous masses¹.

The HT Vista device measures heat transfer rate differences between masses and adjacent normal tissues and then processes that data using machine learning algorithms to classify the masses.

The study evaluated a diverse canine population of 299 dogs with 525 cutaneous and subcutaneous masses.

In the study, the device correctly classified 45 out of 53 malignant masses and 253 out of 378 benign masses (sensitivity = 85% and specificity = 67%).

The negative predictive value of the system (i.e., percent of benign masses identified as benign) was 97%.

This study concluded that the data supports the use of the HT Vista device "as a screening tool and decision support tool for the everyday diagnosis of dermal and subcutaneous masses in general practice, enabling clinicians to differentiate between benign lesions and those requiring additional diagnostics".

Liron Levy-Hirsch, Managing Director of HT Vista’s UK subsidiary said: “We are thrilled to have scientific research validating the success of the HT Vista device.

"The veterinary teams who have already adopted the device into their practice are having great success with it, and with the backing of this newly published paper we hope to reach more practices and ultimately save more dog’s lives.”

www.ht-vet.com / www.ht-vista.uk 

Reference

1. Dank G, Buber T, Rice A, Kraicer N, Hanael E, Shasha T, Aviram G, Yehudayoff A and Kent MS (2023) Training and validation of a novel non-invasive imaging system for ruling out malignancy in canine subcutaneous and cutaneous masses using machine learning in 664 masses. Front. Vet. Sci. 10:1164438. doi: 10.3389/fvets.2023.1164438 https://www.frontiersin.org/articles/10.3389/fvets.2023.1164438/full 

Bayer Animal Health, maker of Advocate and organiser of the Be Lungworm Aware campaign, is warning that last year's damp summer and the mild winter conditions may lead to a continued spread of Angiostongylus vasorum in the UK.

Biodiversity & Conservation Officer for The Natural History Museum, Professor Fred Naggs, said: "An increase in the number of slug and snail populations this year would suggest there will consequently be a continued spread of the parasite. However, this depends on a number of factors: (i) the number of slugs and snails around last year, of which there were many (ii) the level of precipitation throughout the year, as slugs and snails will breed continuously when temperatures are mild to warm and there is adequate relative humidity. According to many reports in the press, last year was one of the wettest on record (iii) the survival of slugs and snails over the winter. As this winter has not been particularly harsh, reasonable numbers of slugs and snails should have survived."

In addition, a study by the RVC as shown that A. vasorum is spreading beyond the traditional geographic distribution with 20 per cent of veterinary practices across the country reporting at least one case of A. vasorum. ¹

To help raise awareness of the parasite, veterinary surgeons and nurses are being encouraged to support the 'Be Lungworm Aware' campaign. The scheme will offer support and education to owners and participating vet practices throughout this month, which has been labelled 'Lungworm Awareness Month'.

Caroline Braidwood, Group Product Manager at Bayer Animal Health said: "While dog owners are becoming more aware of A. vasorum, there is still a real lack of understanding as to the warning signs associated with the condition and how to prevent or treat it. Some owners still believe that Lungworm can be prevented by using normal intestinal wormers which is not the case - Advocate is the only product that can prevent A. vasorum, and from the first application. Our aim with the 'Be Lungworm Aware' campaign is to drive pet owners to their vet practice, where they can then be informed of the danger of the parasite and educated about correct preventative treatment."

Practices can request a range of materials including a practice press pack by calling their Bayer Territory Manager. The pack is designed to promote the awareness campaign to local dog owning clients and includes a regional press release, images and other collateral including leaflets, posters and a campaign DVD for display in waiting rooms.

For more information on lungworm, visit www.lungworm.co.uk

Reference

1. Royal Veterinary College survey 2012, 1,419 veterinary practices

A new expert panel has been formed to evaluate pain management in canine osteoarthritis following a recent shift to a more integrated approach to pain and disease research.

In the past, pain and joint disease have been considered as separate areas of research, with pain perceived simply as a consequence of disease. Over the last few years, however, it has become increasingly apparent that the relationship is far more complex and that pain may be a driver of disease rather than just a consequence of it. The expert panel hopes to apply the new knowledge to the management of joint pain in veterinary practice.

The panel, which had its inaugural meeting in Paris recently, brings together acknowledged veterinary experts in the fields of pain and joint disease. Its focus will be on the assessment and management of pain in canine osteoarthritis (OA), with the objective of educating veterinary surgeons to better understand and manage pain in canine OA and thereby improve the well-being of pets that suffer from this common disease.

'Central sensitisation' is one of the latest theories that has been suggested to explain the complex interaction between pain and disease progression in canine OA. Duncan Lascelles, Associate Professor of Surgery at North Carolina State University, said that research has shown that the components of the pain pathway can change in response to a pain stimulus. Pain receptors 'up-regulate' in response to painful stimuli and become more sensitive to subsequent pain.

CNS sensitisation is likely a significant contributor to chronic or maladaptive pain; this pain leads to decreased mobility, reduced muscle support and reduced muscle function, thus leading to disease progression. In other words, joint diseases cause pain, which in turn feeds back to create more disease.

Professor Lascelles said: "The link between the clinical signs associated with OA and joint pathology is not a simple one and may be much more complex than we have previously thought.

"There is some evidence that COX inhibition reduces central sensitisation. And some evidence suggests that reducing central sensitisation may have a modulatory effect on disease progression by reducing signals going out to the periphery.

"The relationship between pain and disease progression is a very new area of research, and is at the forefront of our knowledge of how pain and joint disease are linked."

Professor John Innes, Head of Division, Small Animal Studies, University of Liverpool Veterinary School, told the meeting that OA is likely to be one of the major reasons for euthanasia of pet dogs in Europe. He and two co-investigators have performed a systematic review of the published evidence for the use of long-term, continuous NSAID treatment (at least 28 days) in OA. They found that this form of management is associated with better outcomes than short-term NSAID therapy, with no evidence of additional safety issues. This review is to be published shortly.

The expert panel comprises:

Prof Dr Stuart Carmichael, Vets Now Ltd. Formerly at: Veterinary School, University of Glasgow, UK
Prof Dr John Innes, Small Animal Teaching Hospital, University of Liverpool, UK
Dr Bernard Bouvy-Centre, Hospitalier Vétérinaire de Frégis, Arcueil, France
Prof Dr Jean-Pierre Genevois, Ecole Nationale Vétérinaire de Lyon, France
Dr Carlos Macías, Centro Veterinario de Referencia Bahia de Malaga, Spain
Prof Dr Martin Kramer, Klinik für Kleintiere, Chirurgie , Justus-Liebig-Universität Gießen, Germany
Dr Sabine Tacke, Klinik für Kleintiere, Chirurgie, Justus-Liebig-Universität Gießen
Prof Dr Duncan Lascelles, North Carolina State University College of Veterinary Medicine, Raleigh, USA
Prof Dr Herman A.W. Hazewinkel, Faculteit Diergeneeskunde, Departement Gezelschapsdieren, Utrecht, Netherlands
Dr Emilio Feltri, Anaesthetist and specialist in Pain Management, Ambulatorio Veterinario Associato, Tortona, Italy
Dr Peter Vandekerckhove, Specialist Surgeon Companion Animal, Wondelgem, Belgium

Vetoquinol - makers of the NSAID Cimalgex - has announced the launch of its updated website www.CiMyDog.co.uk. 

The company says the website has been developed to provide reliable online information about pain in dogs to cater for the increasing needs of pet owners and vets.

The website has two sections. The first is a pet owner focussed, educational tool which takes the visitor on a journey through the process of pain; from spotting the signs of pain all the way through to ways of relieving pain, culminating in the recommendation that the visitor seeks advice from their veterinary practice.

The second section requires registration as it contains more in depth information on the pain process and potential treatment options available, this section is for veterinary professionals only. Also on this section of the website there are many scientific abstracts related to pain and treatment with links to enable the veterinary visitor can view this peer reviewed material.

Robert Simpson, Cimalgex Product Manager said: "The internet is a very powerful tool in terms of increasing education, especially in areas such as canine pain. Unfortunately there can also be a lot of misinformation online and so we felt it was important for Vetoquinol to try and redress the balance by producing www.CiMyDog.co.uk. This can be used as a reliable and up-to-date resource by pet owners and veterinary professionals alike. -

www.CiMyDog.co.uk is a very interactive site which aims to demystify the pain treatment process, ensure pet owners look out for behavioural signs of pain and looks to improve overall canine health with assistance from their veterinary practice. We hope that this will be a valuable resource to which vets can refer their pet owners."

The RCVS Standards Committee has decided to end the temporary dispensation allowing remote prescribing of prescription-only veterinary medicines on Monday 14th March 2022.

The dispensation was originally introduced during the spring 2020 lockdown to safeguard animal health and welfare, the health and safety of the veterinary team, and public health, by allowing prescriptions to be made by veterinary surgeons without their having first physically examined the animal, subject to conditions and safeguards.

The RCVS says the Committee considered the ongoing challenges posed by Covid-19 and recognised that staff absences due to isolation requirements were still causing issues.

However, given the relaxation of the requirement to work from home in England, Scotland and Northern Ireland and relaxation of restrictions generally across the UK, the Committee felt it was time to end the dispensation.

Chair of the Standards Committee, Dr Melissa Donald MRCVS, said: “The safety and wellbeing of veterinary professionals, as well as the health and welfare of the animals they care for, have remained uppermost in our minds when considering this temporary position on remote prescribing.

“We are pleased to have been able to support the professions through a very difficult time by introducing this dispensation, however, it was only ever a temporary measure and, given the relaxation of restrictions across the UK, we feel the time has come to revert to our usual guidance.

“We will continue to keep the position under review in light of any changes, including governments’ advice and regulations, as we have throughout the pandemic.”

TVM is holding Pet Eye Health Awareness Week from 18th - 24th September.

To help veterinary practices engage with pet owners and help them understand the importance of eye health, TVM has produced a range of free educational materials including waiting room displays, informative web pages and social media packs.

The company has also published a page of information at www.tvm-uk.com/eyehealth  – where pet owners can find out more about eye problems, how to spot them and learn what can be done about them.

Emma Hancox MRCVS, Veterinary Advisor at TVM said: "It can be easy for owners to miss the signs of problems with their pet’s eyes, but they can be extremely distressing for animals and be a sign of conditions ranging from cataracts and glaucoma through to conjunctivitis - all of which can be painful, and in the worst-case scenario, lead to blindness.

"We hope that National Pet Eye Health Awareness Week will help practices assist owners in understanding the importance of eye health and prevent more serious conditions occurring."

To request your board kit and pet owner leaflets, and download your free social media pack, visit www.tvm-uk.com/eyehealth or contact your Territory Manager.

VetIT is launching a new suite of practice management software this month, which it claims will wipe out IT support worries while also giving vets secure access to their records wherever there's an internet connection.

Designed for practice-based and mobile vets, its developer says the near-universal access of the system will make VetIT ideal for the progressive and forward-thinking veterinary practice, particularly those with multiple locations.  Early clients are already seeing the benefits of the system, which has been four years in development.

VetIT's Tony Houghton said: "The software offers practices a host of new features, all of them designed to increase usability, enhance revenue, reduce running costs and eliminate IT concerns. And because the new system has been developed in partnership with a well-established veterinary practice, VetIT sees and does things from a vet's perspective.

"During the development phase, our practice partner told us that existing packages were unwieldy - whether in their day-to-day operation, the ability to see and share data, or the 'back office' administration required. So we designed VetIT from scratch, to work in the most user-friendly manner."

According to Mr Houghton, the most significant difference is in how the software works - and in recognising that most practices expect IT systems to 'happen' in the background, rather than devouring precious time.  "Existing packages are physically located in your practice - usually on a dedicated server, requiring daily back-ups and maintenance.

"VetIT, conversely, is a 'web-hosted solution' - like Sage Online or for that matter, Facebook - which means it's accessible to users wherever there's a browser and an internet connection: main or branch practice, home or out in the field.  Log in from anywhere and you'll always see the same data.

 "Practice data is held securely at a remote location and, with automatic back-up systems, some of the biggest worries about onsite IT systems - theft, fire, flooding and protection from computer viruses - are removed immediately.

"In the event of system maintenance or issues, customers talk to a friendly, UK-based support and development team, who can access and modify the system in real time; practices won't have to wait for an engineer to attend.  In fact, we have a very content practice in Oman now running the system; the installation and set-up has all been carried out from a distance."

By removing the 'IT headache', Mr Houghton says practices choosing VetIT will be able to run their businesses more effectively, while developing closer, more valuable relationships with customers.

He said: "The web-based system allows vets' customers to log-in to 'their' VetIT, where they can check records, pay bills, or place orders. Practices can also maintain and build a relationship with customers via e-mail and SMS reminders of appointments, check-ups, treatments due and so on."

As for running costs and pricing, Mr Houghton cites pre-launch studies showing the potential for productivity gains in practices deploying VetIT, while the system's clear pricing - from low-cost start-up practices to corporate licensing for multi-site operations - gives peace of mind with smooth, predictable costs through the system's life.  "You don't have to buy expensive computer hardware like servers and back-up systems, and pay-as-you-go pricing eliminates up-front software licensing costs."

Mr Houghton says users in so-called 'notspots' - areas of the country where broadband connections run at less than 2Mbps or are non-existent - need not feel left out, either.  "We've designed the system to be as fast as possible, with no heavy data-transfer requirements.  In fact, data transfer within the system is so well optimised that it will even work with a dial-up connection or mobile broadband."

More information about VetIT is at http://www.vetit.co.uk/, or contact Nick Cole.